Attached files
| file | filename |
|---|---|
| 10-K - 10-K - scPharmaceuticals Inc. | scph-10k_20201231.htm |
| EX-21.1 - EX-21.1 - scPharmaceuticals Inc. | scph-ex211_9.htm |
| EX-31.1 - EX-31.1 - scPharmaceuticals Inc. | scph-ex311_7.htm |
| EX-4.2 - EX-4.2 - scPharmaceuticals Inc. | scph-ex42_6.htm |
| EX-32.1 - EX-32.1 - scPharmaceuticals Inc. | scph-ex321_11.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Nos. 333-221677, 333-227071, 333-229122, and 333-237361) on Forms S-8 and the Registration Statement (No. 333-229120) on Form S-3 of scPharmaceuticals Inc. of our report dated March 23, 2021, relating to the consolidated financial statements of scPharmaceuticals Inc., appearing in this Annual Report on Form 10-K of scPharmaceuticals Inc. for the year ended December 31, 2020.
/s/ RSM US LLP
Boston, Massachusetts
March 23, 2021
|
|
|
|